Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Bugelski

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Immunopharmacology|March 1, 1992
Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105.685 in the dogP A Thiem, J M Kaplan, P J Bugelski, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 1, 1997
A novel technique for mapping the lipid composition of atherosclerotic fatty streaks by en face fluorescence microscopyA M Klinkner, P J Bugelski, C R Waites, et al.
Toxicologic Pathology|January 1, 1989
Pathogenesis of arterial lesions induced by dopaminergic compounds in the ratW D Kerns, E Arena, R A Macia, et al.
Cancer Research|August 1, 1987
Macrophage content of spontaneous metastases at different stages of growthP J Bugelski, S P Corwin, S M North, et al.
British Journal of Experimental Pathology|April 1, 1989
Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilatorP J Bugelski, C M Vockley, J M Sowinski, et al.
International Journal of Immunopharmacology|April 1, 1993
Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progressionA M Badger, B A Swift, E F Webb, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1991
Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agentJ M Kaplan, A M Badger, E V Ruggieri, et al.
The American Journal of Pathology|March 1, 1992
Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeysP J Bugelski, H A Solleveld, K L Fong, et al.
The American Journal of Physiology|November 1, 1988
Temporal relation between neutrophil accumulation and myocardial reperfusion injuryE F Smith, J W Egan, P J Bugelski, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed ratsR Rabinovici, P J Bugelski, K M Esser, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Immunopharmacology|March 1, 1992
Induction of suppressor cell activity in vivo and suppression of lymphoproliferative responses in vitro by SK&F 105.685 in the dogP A Thiem, J M Kaplan, P J Bugelski, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 1, 1997
A novel technique for mapping the lipid composition of atherosclerotic fatty streaks by en face fluorescence microscopyA M Klinkner, P J Bugelski, C R Waites, et al.
Toxicologic Pathology|January 1, 1989
Pathogenesis of arterial lesions induced by dopaminergic compounds in the ratW D Kerns, E Arena, R A Macia, et al.
Cancer Research|August 1, 1987
Macrophage content of spontaneous metastases at different stages of growthP J Bugelski, S P Corwin, S M North, et al.
British Journal of Experimental Pathology|April 1, 1989
Ultrastructure of an arterial lesion induced in rats by fenoldopam mesylate, a dopaminergic vasodilatorP J Bugelski, C M Vockley, J M Sowinski, et al.
International Journal of Immunopharmacology|April 1, 1993
Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progressionA M Badger, B A Swift, E F Webb, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1991
Inhibition of lymphoproliferative responses by SK&F 105685, a novel anti-arthritic agentJ M Kaplan, A M Badger, E V Ruggieri, et al.
The American Journal of Pathology|March 1, 1992
Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeysP J Bugelski, H A Solleveld, K L Fong, et al.
The American Journal of Physiology|November 1, 1988
Temporal relation between neutrophil accumulation and myocardial reperfusion injuryE F Smith, J W Egan, P J Bugelski, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Tumor necrosis factor-alpha mediates endotoxin-induced lung injury in platelet activating factor-primed ratsR Rabinovici, P J Bugelski, K M Esser, et al.
Pageof 7